CCN4 regulates vascular smooth muscle cell migration and proliferation

Molecules and Cells

Volumn 36, Issue 2, 2013, Pages 112-118

  Liu, Hao ^a   Dong, Wenpeng ^b   Lin, Zhiqi ^a   Lu, Jingbo ^a   Wan, Heng ^a   Zhou, Zhongxin ^a   Liu, Zhengjun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

CCN4; Marker protein; Small interfering RNA; Vascular smooth muscle cell

Indexed keywords

CCN PROTEIN; CCN4 PROTEIN; CYTOKINE; LENTIVIRUS VECTOR; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; IN-STENT RESTENOSIS; INFLAMMATION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

RATTUS;

ANIMALS; ATHEROSCLEROSIS; CCN INTERCELLULAR SIGNALING PROTEINS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORONARY RESTENOSIS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INTEGRIN ALPHA5BETA1; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892953615     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-013-0012-2     Document Type: Article

References (45)

1. Andrés, V., Fuster, J.J., Silvestre-Roig, C., and Wessely, R. (2012). Modulating the proliferative response to treat restenosis after vascular injury. Mol. Trans. Vas. Med. 227-248.
2. Bai, T., Chen, C.C., and Lau, L.F. (2010). Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages. J. Immunol. 184, 3223-3232.
3. Behlke, M.A. (2006). Progress towards in vivo use of siRNAs. Mol. Ther. 13, 644-670.
4. Berschneider, B., and Königshoff, M. (2011). WNT1 inducible signaling pathway protein 1 (WISP1): a novel mediator linking development and disease. Int. J. Biochem. Cell B 43, 306-309.
5. Bonta, P.I., Pols, T.W., van Tiel, C.M., Vos, M., Arkebout, E.K., Rohlena, J., Koch, K.T., de Maat, M.P., Tanck, M.W., de Winter, R. J., et al. (2010). Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation. Circulation 121, 2023-2032.
6. Brigstock, D. (2003). The CCN family: a new stimulus package. J. Endocrinol. 178, 169-175.
7. Chamley-Campbell, J., Campbell, G., and Ross, R. (1979). The smooth-muscle cell in culture. Physiol. Rev. 59, 1-61.
8. Chen, C.C., and Lau, L.F. (2009). Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell B 41, 771-783.
9. Chong, Z.Z., Hou, J., Shang, Y.C., Wang, S., and Maiese, K. (2011). EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes. Curr. Neurovasc. Res. 8, 103-120.
10. Choy, J.C., Granville, D.J., Hunt, D.W.C., and McManus, B.M. (2001). Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell Cardiol. 33, 1673-1690.
11. Cobbold, S., and Waldmann, H. (1981). A rapid solid-phase enzymelinked binding assay for screening monoclonal antibodies to cell surface antigens. J. Immunol. Methods 44, 125-133.
12. Coolong, A., and Kuntz, R.E. (2007). Understanding the drug-eluting stent trials. Am. J. Cardiol. 100, 17-24.
13. Davies, S.R., Leigh Davies, M., Sanders, A., Parr, C., Torkington, J., and Jiang, W.G. (2007). Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. Int. J. Oncol. 36, 1129-1136.
14. Fountaine, T.M., Wood, M.J.A., and Wade-Martins, R. (2005). Delivering RNA interference to the mammalian brain. Curr. Gene Ther. 5, 399-410.
15. Furukawa, Y., Matsumori, A., Ohashi, N., Shioi, T., Ono, K., Harada, A., Matsushima, K., and Sasayama, S. (1999). Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ. Res. 84, 306-314.
16. Griffiths, H., Bakhai, A., West, D., Petrou, M., De Souza, T., Moat, N., Pepper, J., and Di Mario, C. (2004). Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease. Eur. J. Cardiothorac Surg. 26, 528-534.
17. Grinius, V., Navickas, R., and Unikas, R. (2007). Stents in interventional cardiology. Medicina. 43, 183-189.
18. Gupta, G.K., Agrawal, T., Del Core, M.G., Hunter, W.J., and Agrawal, D.K. (2012). Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine. PLoS One 7, e42789.
19. He, B., Reguart, N., You, L., Mazieres, J., Xu, Z., Lee, A.Y., Mikami, I., McCormick, F., and Jablons, D.M. (2005). Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 24, 3054-3058.
20. Hou, C.H., Tang, C.H., Hsu, C.J., Hou, S.M., and Liu, J.F. (2013). CCN4 induces IL-6 production through avb5 receptor, PI3K, Akt, and NF-kB singling pathway in human synovial fibroblasts. Arthrit. Res. Ther. 15, 2-13.
21. Janssens, S., Flaherty, D., Nong, Z., Varenne, O., van Pelt, N., Haustermans, C., Zoldhelyi, P., Gerard, R., and Collen, D. (1998). Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97, 1274-1281.
22. Kramer, M., Balsara, N., Wilhelm, J., Amarie, O.V., Jahn, A., Rose, F., Fink, L., Seeger, W., and Schaefer, L. (2009). WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J. Clin. Invest. 119, 772-787.
23. Lake, A.C., and Castellot, Jr. J.J. (2003). CCN5 modulates the antiproliferative effect of heparin and regulates cell motility in vascular smooth muscle cells. Cell Commun. Signal. 1, 1-13.
24. Li, C., Martinez, V., He, B., Lombet, A., and Perbal, B. (2002). A role for CCN3 (NOV) in calcium signalling. Mol. Pathol. 55, 250-261.
25. Maddaluno, M., Grassia, G., Di Lauro, M.V., Parisi, A., Maione, F., Cicala, C., De Filippis, D., Luvone, T., Guglielnotti, A., Maffia, P., et al. (2012). Bindarit inhibits human c oronary artery smooth muscle cell proliferation, migration and phenotypic switching. PLoS One 7, e47464.
26. Maiese, K., Li, F., Chong, Z.Z., and Shang, Y.C. (2008). The Wnt signaling pathway: aging gracefully as a protectionist? Pharmacol. Therapeut. 118, 58-81.
27. Matchkov, V.V., Kudryavtseva, O., and Aalkjaer, C. (2012). Intracellular Ca 2+ signalling and phenotype of vascular smooth muscle cells. Basic Clin. Pharmacol. Toxicol. 110, 42-48.
28. Matsumae, H., Yoshinori, Y., Ono, K., Togi, K., Inoue, K., Furukawa, Y., Nakashima, Y., Kojima, Y., Nobuyoshi, M., Kita, T., et al. (2008). CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model. Arterioscler. Thromb. Vasc. Biol. 28, 1077-1083.
29. Moiseeva, E.P. (2001). Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc. Res. 52, 372-386.
30. Nikol, S., and Huehns, T. (1996). Molecular biology and post-angioplasty restenosis. Atherosclerosis 123, 17-32.
31. Ono, M., Inkson, C.A., Kilts, T.M., and Young, M.F. (2011). WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J. Bone Miner. Res. 26, 193-208.
32. Pennica, D., Swanson, T.A., Welsh, J.W., Roy, M.A., Lawrence, D. A., Lee, J., Brush, J., Taneyhill, L.A., Deuel, B., and Lew, M. (1998). WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95, 14717-14722.
33. Perbal B. (2004). CCN proteins: multifunctional signalling regulators. Lancet 363, 62-64.
34. Pickering, J.G., Chow, L.H., Li, S., Rogers, K.A., Rocnik, E.F., Zhong, R., and Chan, B.M. (2001). α5β1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury. Am. J. Pathol. 156, 453-465.
35. Rachfal, A.W., and Brigstock, D.R. (2005). Structural and functional properties of CCN proteins. Vitam Horm. 70, 69-103.
36. Rubinson, D.A., Dillon, C.P., Kwiatkowski, A.V., Sievers, C., Yang, L., Kopinja, J., Rooney, D.L., Zhang, M., Ihrig, M.M., and McManus, M.T. (2003). A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406.
37. Schillinger, M., Exner, M., Mlekusch, W., Haumer, M., Sabeti, S., Ahmadi, R., Schwarzinger, I., Wagner, O., and Minar, E. (2003). Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts. J. Endovasc. Ther. 10, 557-565.
38. Schutze, N., Noth, U., Schneidereit, J., Hendrich, C., and Jakob, F. (2005). Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun. Signal. 3, 5.
39. Shanahan, C.M., and Weissberg, P.L. (1998). Smooth muscle cell heterogeneity patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscl. Throm. Vas. 18, 333-338.
40. Shimoyama, T., Hiraoka, S., Takemoto, M., Koshizaka, M., Tokuyama, H., Tokuyama, T., Watanabe, A., Fujimoto, M., Kawamura, H., Sato, S., et al. (2010). CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arterioscler. Thromb. Vasc. Biol. 30, 675-682.
41. Wang, H., Zhang, R., Wen, S., McCafferty, D.M., Beck, P.L., and MacNaughton, W.K. (2009a). Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis. J. Mol. Med. 87, 435-445.
42. Wang, L., Zheng, J., Bai, X., Liu, B., Liu, C.J., Xu, Q., Zhu, Y., Wang, N., Kong, W., and Wang, X. (2009b). ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ. Res. 104, 688-698.
43. Weintraub, W.S. (2007). The pathophysiology and burden of restenosis. Am. J. Cardiol. 100, 36-46.
44. Yoshida, Y., Togi, K., Matsumae, H., Nakashima, Y., Kojima, Y., Yamamoto, H., Ono, K., Nakamura, T., Kita, T., and Tanaka, M. (2007). CCN1 protects cardiac myocytes from oxidative stress via β1 integrin-Akt pathway. Biochem. Biophys. Res. Commun. 355, 611-618.
45. Zahedmanesh, H., and Lally, C. (2009). Determination of the influence of stent strut thickness using the finite element method: implications for vascular injury and in-stent restenosis. Med. Biol. Eng. Comput. 47, 385-393.